NCT05383482 2025-11-17Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1Laekna LimitedPhase 1/2 Completed22 enrolled
NCT03099382 2024-01-22Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Completed457 enrolled 9 charts
NCT02564263 2023-03-13KEYNOTE-181Merck Sharp & Dohme LLCPhase 3 Completed628 enrolled 27 charts 1 FDA
NCT02569242 2022-07-06Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal CancerOno Pharmaceutical Co. LtdPhase 3 Completed419 enrolled 20 charts 2 FDA
NCT01822613 2020-12-19Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)NovartisPhase 1 Completed48 enrolled